CAMP4 Therapeutics Corp. (CAMP)
4.15
-0.02
(-0.48%)
USD |
NASDAQ |
Sep 22, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
CAMP4 Therapeutics Debt to Equity Ratio : -3.423 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.423 |
| March 31, 2026 | 0.0687 |
| December 31, 2025 | 0.0414 |
| September 30, 2025 | 0.1082 |
| June 30, 2025 | 0.1806 |
| March 31, 2025 | 0.1544 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.1383 |
| September 30, 2024 | 3.039 |
| June 30, 2024 | 0.6997 |
| March 31, 2024 | |
| December 31, 2023 | 0.3171 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| MannKind Corp. | -6.494 |
| Ocugen, Inc. | -5.314 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 93.43M |
| Total Liabilities (Quarterly) | 94.12M |
| Shareholders Equity (Quarterly) | -0.693M |
| Current Ratio | 4.703 |
| Net Debt Paydown Yield | 0.49% |